These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Association of a murine leukaemia stem cell gene signature based on nucleostemin promoter activity with prognosis of acute myeloid leukaemia in patients. Ali MA; Naka K; Yoshida A; Fuse K; Kasada A; Hoshii T; Tadokoro Y; Ueno M; Ohta K; Kobayashi M; Takahashi C; Hirao A Biochem Biophys Res Commun; 2014 Jul; 450(1):837-43. PubMed ID: 24960197 [TBL] [Abstract][Full Text] [Related]
5. Bringing a Leukemic Stem Cell Gene Signature into Clinics: Are We There Yet? Richard-Carpentier G; Sauvageau G Cell Stem Cell; 2017 Mar; 20(3):300-301. PubMed ID: 28257710 [TBL] [Abstract][Full Text] [Related]
7. The rarity of ALDH(+) cells is the key to separation of normal versus leukemia stem cells by ALDH activity in AML patients. Hoang VT; Buss EC; Wang W; Hoffmann I; Raffel S; Zepeda-Moreno A; Baran N; Wuchter P; Eckstein V; Trumpp A; Jauch A; Ho AD; Lutz C Int J Cancer; 2015 Aug; 137(3):525-36. PubMed ID: 25545165 [TBL] [Abstract][Full Text] [Related]
8. Relevance of leukemic stem cells in acute myeloid leukemia: heterogeneity and influence on disease monitoring, prognosis and treatment design. Wouters R; Cucchi D; Kaspers GJ; Schuurhuis GJ; Cloos J Expert Rev Hematol; 2014 Dec; 7(6):791-805. PubMed ID: 25242511 [TBL] [Abstract][Full Text] [Related]
9. Gene expression profiling in the leukemic stem cell-enriched CD34+ fraction identifies target genes that predict prognosis in normal karyotype AML. de Jonge HJ; Woolthuis CM; Vos AZ; Mulder A; van den Berg E; Kluin PM; van der Weide K; de Bont ES; Huls G; Vellenga E; Schuringa JJ Leukemia; 2011 Dec; 25(12):1825-33. PubMed ID: 21760593 [TBL] [Abstract][Full Text] [Related]
10. [Current clinical trials using new targeted therapies for myeloid leukemia and the research trends]. Ishizawa J; Saya H Nihon Rinsho; 2009 Oct; 67(10):1932-7. PubMed ID: 19860193 [TBL] [Abstract][Full Text] [Related]
11. Identification of a subset of patients with acute myeloid leukemia characterized by long-term in vitro proliferation and altered cell cycle regulation of the leukemic cells. Hatfield KJ; Reikvam H; Bruserud Ø Expert Opin Ther Targets; 2014 Nov; 18(11):1237-51. PubMed ID: 25200484 [TBL] [Abstract][Full Text] [Related]
12. Entinostat prevents leukemia maintenance in a collaborating oncogene-dependent model of cytogenetically normal acute myeloid leukemia. Ramsey JM; Kettyle LM; Sharpe DJ; Mulgrew NM; Dickson GJ; Bijl JJ; Austin P; Mayotte N; Cellot S; Lappin TR; Zhang SD; Mills KI; Krosl J; Sauvageau G; Thompson A Stem Cells; 2013 Jul; 31(7):1434-45. PubMed ID: 23592435 [TBL] [Abstract][Full Text] [Related]
17. Early gene expression of acute myeloid leukemia in response to chemotherapy. Anensen N; Øyan AM; Huseby S; Kalland KH; Bruserud Ø; Gjertsen BT Expert Rev Anticancer Ther; 2007 May; 7(5):741-51. PubMed ID: 17492937 [TBL] [Abstract][Full Text] [Related]
18. Differential chemosensitivity of leukemic cells in the myeloid and lymphoid phases of stem cell leukemia (a case report). Mihál V; Hajdúch M; Dusek J; Jarosová M; Weigl E; Pikalová Z; Indrák K; Safárová M; Janostáková A Neoplasma; 1997; 44(2):133-6. PubMed ID: 9201294 [TBL] [Abstract][Full Text] [Related]